Systematic Review of Robotic-Assisted Laparoscopic Ureterocalicostomy Applications
Overview
Robotic-assisted laparoscopic ureterocalicostomy (RALUC) is an emerging minimally invasive technique used to treat complex ureteropelvic junction obstruction (UPJO) and proximal ureteral strictures. This systematic review summarizes eight studies involving both adult and pediatric patients, demonstrating the feasibility, safety, and efficacy of RALUC with promising surgical outcomes.
Background
Ureterocalicostomy is a surgical procedure connecting the ureter to the lower pole calyx after excision of hydronephrotic kidney parenchyma, primarily indicated for complex UPJO cases and failed prior reconstructions. Traditional open surgery has been the standard, but advances in minimally invasive surgery have introduced laparoscopic and robotic-assisted approaches. Robotic-assisted laparoscopic ureterocalicostomy offers enhanced precision, 3D visualization, and improved ergonomics, potentially improving delicate dissection and suturing in complex cases. This review evaluates the current evidence on RALUC applications in both adults and children.
Data Highlights
Study
Year
Population
Number of Patients
Robotic Platform
Study Design
Level of Evidence
Casale et al.
2008
Pediatric
4
Not defined
Case-series
4
Stolzenburg et al.
2025
Adult
24
Defined robotic system
Case-series
4
Other 6 studies
2008-2025
Adult and Pediatric
4-24
Mixed/Not defined
Mostly case-series, 1 retrospective comparative
4 (7 studies), 2b (1 study)
Key Findings
RALUC is applied in both adult and pediatric populations for complex UPJO and proximal ureteral strictures.
The procedure is indicated after failed pyeloplasty, complicated renal anatomy, and long ureteral strictures.
Robotic-assisted surgery provides enhanced precision, 3D visualization, and ergonomic advantages over open and conventional laparoscopic approaches.
Included studies were mostly small case-series with low levels of evidence (mostly level 4), reflecting the rarity of RALUC.
Reported outcomes indicate feasibility, safety, and promising success rates, though comparative data remain limited.
One study compared robotic and laparoscopic ureterocalicostomy with pyeloplasty, but data were not separately reported for robotic versus laparoscopic ureterocalicostomy.
Clinical Implications
RALUC represents a viable minimally invasive alternative for managing complex UPJO and proximal ureteral strictures, especially in patients with challenging anatomy or failed prior surgeries. Surgeons should consider the robotic approach for its technical advantages in delicate dissection and suturing, although further high-quality comparative studies are needed to establish definitive benefits. Patient selection remains critical given the procedure's specialized indications.
Conclusion
Robotic-assisted laparoscopic ureterocalicostomy is a promising technique for complex upper urinary tract reconstructions, demonstrating feasibility and safety in limited case-series. Continued research with larger cohorts and comparative designs is necessary to validate its efficacy and define its role relative to other surgical approaches.
References
Casale et al. 2008 -- Robotic-Assisted Laparoscopic Ureterocalicostomy
Stolzenburg et al. 2025 -- Recent Advances in RALUC
Congenital thrombotic thrombocytopenic purpura (cTTP) is a rare autosomal recessive condition that causes deficiency of the von Willebrand factor (vWF)-cleaving metalloprotease, ADAMTS13. Recombinant ADAMTS13 (rADAMTS13) is the first FDA-approved product for management of cTTP. This article reviews the pharmacology, pharmacokinetics, efficacy, safety, dosing, administration, and implications for advanced practitioners of rADAMTS13.
This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from December 1 - 15.
